Browsing by Author Yang, Mo

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2009Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancerQiao, Liang; Chan, Kwok Wah; Dai, Yun; et al, various; Lam, Colin; Ma, Juan; Wang, Jide; Yang, Mo; Ye, Jieyu; Zhang, Rongxin; Zou, Bing; Western Clinical School: Medicine (Westmead)Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer, Molecular Cancer Therapeutics, vol.8, 9,pp 2762-2770
2010Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathwayQiao, Liang; Chan, Godfrey Chi Fung; Chen, Jian Liang; Chong, Beng H; Deng, Ruixia; Khachigian, Levon M.; Lian, Qizhou; Luo, Xue Qun; Ma, Ming; Meng, Fan Yi; Yang, Mo; Ye, Jieyu; Western Clinical School: Medicine (Westmead)Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway, Haematologica: the hematology journal, vol.95, 10,pp 1745-1753
2012Role of PCDH10 and its hypermethylation in human gastric cancerQiao, Liang; Chim, James; Li, Zesong; Wong, Benjamin Chun Yu; Yang, Mo; Ye, Jieyu; Western Clinical School: Medicine (Westmead)Role of PCDH10 and its hypermethylation in human gastric cancer, BBA: Biochimica et Biophysica Acta - Molecular Cell Research, vol.1823, 2, 2012,pp 298-305
2012Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-kB pathwaysQiao, Liang; Huang, Kai-Kai; Jiang, Xue-Jie; Meng, Fan Yi; Wang, Qiang; Wang, Zhi-Xiang; Wu, Fu-Qun; Yang, Mo; Ye, Jie-Yu; Yi, Zheng-Shan; Zhou, Hong-Sheng; Zhou, Qing-Xia; Western Clinical School: Medicine (Westmead)Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-kB pathways, Cancer Letters, vol.326, 2, 2012,pp 135-142